Assertio Holdings (ASRT) Long-Term Investments (2019 - 2020)

Assertio Holdings' (ASRT) quarterly Long-Term Investments came in at $1.6 million in Q4 2020, down 87.91% year-on-year from $13.1 million in Q1 2020, and little changed quarter-over-quarter from $1.6 million in Q2 2020.

Assertio Holdings (ASRT) Long-Term Investments (2019 - 2020) Analysis & Trends

Assertio Holdings has disclosed Long-Term Investments across 2 years of filings, most recently posting $1.6 million for Q4 2020.

  • Long-Term Investments for Q4 2020 came in at $1.6 million, down 87.91% year-over-year; the trailing twelve-month figure through Dec 2020 was $1.6 million (down 87.91% YoY), and the FY2020 annual result was $1.6 million, down 87.91% from the prior year.
  • Long-Term Investments came in at $1.6 million for Q4 2020 at Assertio Holdings, roughly flat from $1.6 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $13.1 million in Q4 2019 to a low of $1.6 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 1.32 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.33 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 26.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.90 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 1.58 Mn
Jun 30, 2020 1.58 Mn
Dec 31, 2019 13.06 Mn